🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
491 results for “Novo”
MedicineActive substanceLicence holderStatus
Fiasp 100 units/mL FlexTouch solution for injection in pre-filled pen
EU/1/16/1160/001-006
Insulin aspart Novo Nordisk A/S
Fingolimod Krka 0.5 mg hard capsules
PA1347/101/001
FINGOLIMOD HYDROCHLORIDE KRKA, d.d., Novo mesto Marketed
Galsya SR 16 mg prolonged-release capsules, hard
PA1347/015/002
Galantamine KRKA, d.d., Novo mesto Marketed
Galsya SR 24 mg prolonged-release capsules, hard
PA1347/015/003
Galantamine KRKA, d.d., Novo mesto Marketed
Galsya SR 8 mg prolonged-release capsules, hard
PA1347/015/001
Galantamine KRKA, d.d., Novo mesto Marketed
GlucaGen HypoKit 1 mg powder and solvent for solution for injection
PA0218/031/002
GLUCAGON Novo Nordisk A/S Marketed
Icorvida SR 1.5mg Prolonged-release Tablets
PA1347/022/001
Indapamide KRKA, d.d., Novo mesto Marketed
Ifirmacombi 150 mg/12.5 mg film-coated tablets
EU/1/11/673/001-008
Hydrochlorothiazide, Irbesartan KRKA, d.d., Novo mesto
Ifirmacombi 300 mg/12.5 mg film-coated tablets
EU/1/11/673/009-016
Hydrochlorothiazide, Irbesartan KRKA, d.d., Novo mesto
Ifirmacombi 300 mg/25 mg film-coated tablets
EU/1/11/673/017-024
Hydrochlorothiazide, Irbesartan KRKA, d.d., Novo mesto
Ifirmasta 150 mg film-coated tablets
EU/1/08/480/7-12
Irbesartan KRKA, d.d., Novo mesto
Ifirmasta 300 mg film-coated tablets
EU/1/08/480/13-18
Irbesartan KRKA, d.d., Novo mesto
Ifirmasta 75 mg film-coated tablets
EU/1/08/480/1-6
Irbesartan KRKA, d.d., Novo mesto
Imatinib Krka d.d 100 mg film-coated tablets
PA1347/054/001
Imatinib KRKA, d.d., Novo mesto Marketed
Imatinib Krka d.d. 400 mg film-coated tablets
PA1347/054/002
Imatinib KRKA, d.d., Novo mesto Marketed
Insulatard
EU/1/02/233/1-15
Insulin human Novo Nordisk A/S
Insulatard 100 international units/ml suspension for injection in vial
EU/1/02/233/003-004
Insulin human Novo Nordisk A/S
Insulatard FlexPen
EU/1/02/233/013
Insulin human Novo Nordisk A/S
Insulatard InnoLet
EU/1/02/233/010-012
Insulin human Novo Nordisk A/S
Insulatard Penfill
EU/1/02/233/005-007
Insulin human Novo Nordisk A/S
Ivabradine Krka 5 mg film-coated tablets
PA1347/065/001
Ivabradine KRKA, d.d., Novo mesto Marketed
Ivabradine Krka 7.5 mg film-coated tablets
PA1347/065/002
Ivabradine KRKA, d.d., Novo mesto Marketed
Kamiren 4 mg prolonged-release tablets
PA1347/038/001
Doxazosin KRKA, d.d., Novo mesto Marketed
Kliogest 2 mg/1 mg film-coated tablets
PA0218/022/001
Estradiol, Norethisterone acetate Novo Nordisk A/S Marketed
Lacosamide Krka 100 mg film-coated tablets
PA1347/099/002
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 150 mg film-coated tablets
PA1347/099/003
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 200 mg film-coated tablets
PA1347/099/004
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 50 mg film-coated tablets
PA1347/099/001
Lacosamide KRKA, d.d., Novo mesto Marketed
Lansoprazole Krka 15 mg Gastro-resistant Capsules, hard
PA1347/062/001
Lansoprazole KRKA, d.d., Novo mesto Marketed
Lansoprazole Krka 30 mg Gastro-resistant Capsules, hard
PA1347/062/002
Lansoprazole KRKA, d.d., Novo mesto Marketed
Lenalidomide Krka 10 mg hard capsules
EU/1/20/1519/007-008
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 15 mg hard capsules
EU/1/20/1519/009-010
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 2.5 mg hard capsules
EU/1/20/1519/001-002
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 20 mg hard capsules
EU/1/20/1519/011-012
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 25 mg hard capsules
EU/1/20/1519/013-014
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 5 mg hard capsules
EU/1/20/1519/003-004
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 7.5 mg hard capsules
EU/1/20/1519/005-006
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
LEVEMIR (INSULIN DETEMIR)
EU/1/04/278/1-9
Insulin detemir Novo Nordisk A/S
Levemir 100 units/ml Solution for injection in pre-filled pen
EU/1/04/278/010-011
Insulin determir Novo Nordisk A/S
Levocetirizine Krka 5mg film-coated tablets
PA1347/043/001
Levocetirizine dihydrochloride KRKA, d.d., Novo mesto Marketed
Levofloxacin Krka 250 mg film-coated tablets
PA1347/048/001
Levofloxacin KRKA, d.d., Novo mesto Marketed
Levofloxacin Krka 500 mg film-coated tablets
PA1347/048/002
Levofloxacin KRKA, d.d., Novo mesto Marketed
Linagliptin Krka 5 mg film-coated tablets
PA1347/120/001
Linagliptin KRKA, d.d., Novo mesto Not marketed
Linezolid 2 mg/ml solution for infusion
PA1347/057/002
Linezolid KRKA, d.d., Novo mesto Marketed
Linezolid Krka 600 mg film-coated tablets
PA1347/057/001
Linezolid KRKA, d.d., Novo mesto Marketed
Losartan Krka 100 mg film-coated tablets
PA1347/020/003
Losartan potassium KRKA, d.d., Novo mesto Marketed
Losartan Krka 25 mg film-coated tablets
PA1347/020/001
Losartan potassium KRKA, d.d., Novo mesto Not marketed
Losartan Krka 50 mg film-coated tablets
PA1347/020/002
Losartan potassium KRKA, d.d., Novo mesto Marketed
Losartan/Hydrochlorothiazide Krka 100 mg/12.5 mg film-coated tablets
PA1347/040/002
Losartan potassium, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Losartan/Hydrochlorothiazide Krka 100 mg/25 mg film-coated tablets
PA1347/040/003
Losartan potassium, Hydrocholothiazide KRKA, d.d., Novo mesto Marketed
1 2 3 4 5 6 7

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.